Clinical trial
High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux…
NCT00461604 · Technical University of Munich, Other · Completed
Key facts
| NCT number | NCT00461604 |
|---|---|
| Title | High Dosage Esomeprazole and Baclofen for Therapy of Gastroesophageal Reflux Disease |
| Acronym | NEXBAC |
| Lead sponsor | Technical University of Munich, Other |
| Status | Completed |
| Study type | Observational |
| Conditions | Patients With Persistent Objectified Gastroesophageal Reflux and Reflux-Associated Symptoms Despite PPI-Therapy With 40mg Esomeprazole |
| Enrollment | 40 |
| Start date | Oct 1, 2006 |
| Primary completion | May 1, 2008 |
| Completion | May 1, 2008 |
| First posted | Apr 18, 2007 |
| Last update posted | May 20, 2008 |
| Countries | Germany |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: